About: Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2000 (uk) im Februar 2000 veröffentlichter wissenschaftlicher Artikel (de) wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch (gsw) article scientifique publié en février 2000 (fr) artículu científicu espublizáu en febreru de 2000 (ast) artikull shkencor i botuar më 01 shkurt 2000 (sq) scientific article published on 01 February 2000 (en)
publication date	wds:Q60146859-A44B6034-9F32-45A0-B573-5FE15748B166
publication date	2000-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60146859-EF6181B1-AC3E-44A4-8C9F-7427E6A9D147
language of work or name	English
author name string	wds:Q60146859-02AF2FDE-A7BF-4389-BABF-333CF5F4C142 wds:Q60146859-1F2319D4-926E-4735-9EEB-356B43C7427D wds:Q60146859-27125464-53B4-4DD5-B7C5-CA27FB8ECCE3 wds:Q60146859-273066D7-3978-42FC-9AC4-5743861D6A5D wds:Q60146859-4B37A44E-7579-4C85-9291-2E723F51D694 wds:Q60146859-D0A539C3-98D1-41CD-9225-3DD1545BFA6B wds:Q60146859-DAACFCF9-4B20-4D29-BF3A-1D7F3E7F50FA wds:Q60146859-F147B734-D440-42F6-A179-78EA3E5F0C3C
author name string	Clark RH Kinsella JP Southgate WM Walker MW Huckaby JL Kueser TJ Perez JA Roy BJ
rdfs:label	Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (en) Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (nl) Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (sq)
skos:prefLabel	Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (en) Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (nl) Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (sq)
name	Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (en) Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (nl) Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn (sq)
author	wds:Q60146859-1A8FB6DF-ACFE-4742-92B6-4F18112E38E2
author	Martin Keszler
title	wds:Q60146859-CA83CCCC-58EF-4F87-8D7F-306B76F25329
title	Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group (en)
page(s)	wds:Q60146859-8CC95532-5CDE-4494-BFA4-B67B7810C1B9
page(s)	469-474
instance of	wds:Q60146859-8B2AF2EC-3377-4670-B972-DB588E2FB80D
instance of	scholarly article
main subject	wds:Q60146859-B85633E7-3158-4DE5-9127-9206D27D0A09
main subject	persistent fetal circulation syndrome
PubMed ID	wds:Q60146859-FC1AA3DD-18F9-4F95-8894-71734CB088F3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10675427
PubMed ID	10675427
published in	wds:Q60146859-020B79E5-4D25-44EF-9D60-C8F3CD89F8C8
published in	The New England Journal of Medicine
issue	wds:Q60146859-E916720B-0AB3-4D94-BEE2-04E3A71CD358
volume	wds:Q60146859-0BB64354-6118-4527-912B-9B8DB351FCD1
issue	7
volume	342
DOI	wds:Q60146859-E3655C68-0E75-4236-9793-D2EAB64693F9
DOI	http://dx.doi.org/10.1056/NEJM200002173420704
DOI	10.1056/NEJM200002173420704
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60146859
is cites work of	Utility of large-animal models of BPD: chronically ventilated preterm lambs Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up CO and NO pulmonary diffusing capacity during pregnancy: Safety and diagnostic potential Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn Neonatal pulmonary hypertension Oxidants, nitrosants, and the lung The direct and indirect action of inhaled agents on the lung and its circulation: lessons for clinical science Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults Inhaled Nitric Oxide for Acute Hypoxic Respiratory Failure in Children and Adults: A Meta-analysis Pediatric pulmonary arterial hypertension: current and emerging therapeutic options Nitric oxide for respiratory failure in infants born at or near term Endothelial nitric oxide synthase (NOS) is upregulated in rapid progressive pulmonary hypertension of the newborn Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator Inhaled NO as a therapeutic agent Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. Can nitric oxide-based therapy prevent bronchopulmonary dysplasia? Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure. Inhaled nitric oxide in the management of preterm infants with severe respiratory failure Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. Inhaled nitric oxide therapy during the transport of neonates with persistent pulmonary hypertension or severe hypoxic respiratory failure Clinical translation of nitrite therapy for cardiovascular diseases Endothelium-dependent control of vascular tone during early postnatal and juvenile growth Drug treatment of pulmonary hypertension in children Inhaled nitric oxide decreases leukocyte trafficking in the neonatal mouse lung during exposure to >95% oxygen Opposing regulation of human alveolar type II cell differentiation by nitric oxide and hyperoxia Nitric oxide counteracts the hyperoxia-induced proliferation and proinflammatory responses of mouse astrocytes Nitrite signaling in pulmonary hypertension: mechanisms of bioactivation, signaling, and therapeutics Epigenetic regulation of pulmonary arterial hypertension Oxygen saturation index and severity of hypoxic respiratory failure Clinical classification of pulmonary hypertension Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure Can we improve outcome of congenital diaphragmatic hernia?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software